Evidence map›Paper›PMID 28134809›Full record

ReviewInternational journal of molecular sciences2017

Hormetic Response to Low-Dose Radiation: Focus on the Immune System and Its Clinical Implications.

Jiuwei Cui, Guozi Yang, Zhenyu Pan, Yuguang Zhao, Xinyue Liang, Wei Li, Lu Cai

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 92 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Radiotherapy for non-cancer diseases: benefits and long-term risks.International journal of radiation biology · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. COVID-19 and low-dose radiation therapy.Radiation medicine and protection · 2021
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jiuwei CuiCancer Center, the First Hospital of Jilin University, Changchun 130021, China. cuijw@jlu.edu.cn.
Guozi YangCancer Center, the First Hospital of Jilin University, Changchun 130021, China. ygz@jlu.edu.cn.
Zhenyu PanDepartment of Radiation-Oncology, the First Hospital of Jilin University, Changchun 130021, China. pzy@jlu.edu.cn.
Yuguang ZhaoCancer Center, the First Hospital of Jilin University, Changchun 130021, China. zhaoyuguang@jlu.edu.cn.
Xinyue LiangCancer Center, the First Hospital of Jilin University, Changchun 130021, China. xyliang80@gmail.com.
Wei LiCancer Center, the First Hospital of Jilin University, Changchun 130021, China. liwei66@jlu.edu.cn.
Lu CaiCancer Center, the First Hospital of Jilin University, Changchun 130021, China. L0cai001@louisville.edu.
Jilin University · CNUniversity of Louisville · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interrelationship between ionizing radiation and the immune system is complex, multifactorial, and dependent on radiation dose/quality and immune cell type. High-dose radiation usually results in immune suppression. On the contrary, low-dose radiation (LDR) modulates a variety of immune responses that have exhibited the properties of immune hormesis. Although the underlying molecular mechanism is not fully understood yet, LDR has been used clinically for the treatment of autoimmune diseases and malignant tumors. These advancements in preclinical and clinical studies suggest that LDR-mediated immune modulation is a well-orchestrated phenomenon with clinical potential. We summarize recent developments in the understanding of LDR-mediated immune modulation, with an emphasis on its potential clinical applications.

Indexed as

AnimalsDose-Response Relationship, RadiationHormesisHumansImmune SystemModels, Biologicalautoimmune diseasecancer therapyhormesisimmune stimulatingimmune therapylow-dose radiation

Identifiers

PMID28134809
PMCPMC5343816
OpenAlexW2582143511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.